259 related articles for article (PubMed ID: 22991882)
21. Is the group of older sickle cell disease patients from Trinidad and Tobago different?
Losada R; Bravo I; Capildeo K; Charles K
Am J Hematol; 2006 Mar; 81(3):219-20. PubMed ID: 16493601
[No Abstract] [Full Text] [Related]
22. [Study of hemoglobinopathies found in Belgium].
Fondu P
Bull Mem Acad R Med Belg; 1995; 150(10-11):367-75; discussion 376-8. PubMed ID: 8845787
[TBL] [Abstract][Full Text] [Related]
23. Proportion of adults with sickle cell anemia and pain crises receiving hydroxyurea.
Stettler N; McKiernan CM; Melin CQ; Adejoro OO; Walczak NB
JAMA; 2015 Apr; 313(16):1671-2. PubMed ID: 25919532
[No Abstract] [Full Text] [Related]
24. Approach to the vaso-occlusive crisis in adults with sickle cell disease.
Yale SH; Nagib N; Guthrie T
Am Fam Physician; 2000 Mar; 61(5):1349-56, 1363-4. PubMed ID: 10735342
[TBL] [Abstract][Full Text] [Related]
25. Sickle cell pain crisis.
Davies SC; Bevan DH
Lancet; 1996 Jan; 347(8996):263. PubMed ID: 8551907
[No Abstract] [Full Text] [Related]
26. Hydroxyurea for children with sickle cell disease.
Heeney MM; Ware RE
Pediatr Clin North Am; 2008 Apr; 55(2):483-501, x. PubMed ID: 18381097
[TBL] [Abstract][Full Text] [Related]
27. Sickle cell disease--pathophysiology and treatment.
Redding-Lallinger R; Knoll C
Curr Probl Pediatr Adolesc Health Care; 2006; 36(10):346-76. PubMed ID: 17055417
[No Abstract] [Full Text] [Related]
28. The association of oral hydroxyurea therapy with improved cognitive functioning in sickle cell disease.
Puffer E; Schatz J; Roberts CW
Child Neuropsychol; 2007 Mar; 13(2):142-54. PubMed ID: 17364571
[TBL] [Abstract][Full Text] [Related]
29. Treatment adherence in patients with sickle cell anemia.
Drotar D
J Pediatr; 2010 Mar; 156(3):350-1. PubMed ID: 20056235
[No Abstract] [Full Text] [Related]
30. MRI abnormalities in infants with sickle cell anemia-indication for preemptive therapy?
Ozsahin H
Pediatr Blood Cancer; 2008 Nov; 51(5):573-4. PubMed ID: 18623220
[No Abstract] [Full Text] [Related]
31. Long-term results using hydroxyurea/phlebotomy for reducing secondary stroke risk in children with sickle cell anemia and iron overload.
Greenway A; Ware RE; Thornburg CD
Am J Hematol; 2011 Apr; 86(4):357-61. PubMed ID: 21442640
[TBL] [Abstract][Full Text] [Related]
32. Pathogenesis and treatment of acute chest syndrome of sickle-cell anaemia.
Gladwin MT; Rodgers GP
Lancet; 2000 Apr; 355(9214):1476-8. PubMed ID: 10801164
[No Abstract] [Full Text] [Related]
33. Hydroxycarbamide use in young children with sickle-cell anaemia.
Takahashi Y; Mori J; Tsubokura M; Matsumura T; Kami M
Lancet; 2011 Nov; 378(9805):1777. PubMed ID: 22098851
[No Abstract] [Full Text] [Related]
34. Hydroxycarbamide use in young children with sickle-cell anaemia.
Obaro SK; Inusa B; Telfer P
Lancet; 2011 Nov; 378(9805):1777. PubMed ID: 22098850
[No Abstract] [Full Text] [Related]
35. [Treatment with hydroxyurea has revolutionized the evolution of sickle cell disease ].
Bartolucci P; de Montalembert M
Rev Prat; 2014 Oct; 64(8):1127-8. PubMed ID: 25510141
[No Abstract] [Full Text] [Related]
36. Hydroxyurea for sickle cell anemia.
Bachmeyer C; Aractingi S; Lionnet F
N Engl J Med; 2008 Jul; 359(1):98; author reply 98-9. PubMed ID: 18609755
[No Abstract] [Full Text] [Related]
37. Sickle cell disease: taking a multidisciplinary approach.
Apanah S; Rizzolo D
JAAPA; 2013 Aug; 26(8):28-33. PubMed ID: 24049937
[TBL] [Abstract][Full Text] [Related]
38. Hydroxyurea use in patients with sickle cell disease in a Medicaid population.
Ritho J; Liu H; Hartzema AG; Lottenberg R
Am J Hematol; 2011 Oct; 86(10):888-90. PubMed ID: 21922530
[No Abstract] [Full Text] [Related]
39. Hydroxyurea for children with sickle cell disease: are we starting too late?
Mueller BU
Pediatr Blood Cancer; 2011 Jan; 56(1):3-4. PubMed ID: 21058289
[No Abstract] [Full Text] [Related]
40. Sickle cell disease.
McCavit TL
Pediatr Rev; 2012 May; 33(5):195-204; quiz 205-6. PubMed ID: 22550263
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
